Boxer Capital Management, LLC - 10 Oct 2024 Form 3 Insider Report for Tyra Biosciences, Inc. (TYRA)

Role
Other*
Signature
BOXER CAPITAL MANAGEMENT, LLC By: Aaron I. Davis, Managing Member /s/ Aaron I. Davis
Issuer symbol
TYRA
Transactions as of
10 Oct 2024
Net transactions value
$0
Form type
3
Filing time
22 Oct 2024, 20:47:40 UTC
Next filing
22 Oct 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TYRA Common Stock 6,448,349 10 Oct 2024 See footnote F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TYRA Warrant (right to purchase) 10 Oct 2024 Common Stock 705,280 $13.01 See footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are held indirectly by Boxer Capital Management, LLC ("BCM") as the investment manager of an account holding such securities. BCM disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
F2 These Warrants are exercisable immediately (subject to any applicable beneficial ownership limitation) and do not have an expiration date.

Remarks:

As of the date of the event requiring statement, the Reporting Person may have been deemed a member of a group that beneficially owned more than 10% of the outstanding shares of the common stock, par value $0.001 of the Issuer. Dr. Siddarth Subramony, a managing director of Boxer Capital, LLC, serves as a member of the Issuer's board of directors. On the basis of the relationship between Dr. Subramony and the Reporting Person, the Reporting Person may be considered a director of the Issuer for purposes of Section 16 of the Securities Exchange Act of 1934, as amended.